AstraZeneca_NN
Annual_JJ
Report_NN
and_PHC
Financial_NN
Statements_NOMZ
74_CD
Form_NN
20-F_JJ
Information_NOMZ
2003_CD
Notes_NN
to_PIN
the_DT
Financial_NN
Statements_NOMZ
continued_VBD
6_CD
Dividends_NN
to_PIN
shareholders_NN
2003 2002 2001 2003_CD
2002_CD
2001_CD
Per_PIN
Per_PIN
Per_PIN
share_NN
share_NN
share_NN
$_$
m_CD
$_$
m_CD
$_$
m_CD
Interim_NN
,_,
paid_VBN [PASTP]
on_PIN
6_CD
October_NN
2003_CD
$_$
0.255_CD
$_$
0.23_CD
$_$
0.23_CD
436 398 405_CD
Second_JJ
interim_NN
,_,
to_TO
be_VB [PASS]
confirmed_VBN [PUBV]
as_IN
final_JJ
,_,
payable_JJ
6_CD
April_NN
2004_CD
$_$
0.540_CD
$_$
0.47_CD
$_$
0.47_CD
914 808 820_CD
$_$
0.795_CD
$_$
0.70_CD
$_$
0.70_CD
1,350_CD
1,206_CD
1,225_CD
7_CD
Earnings_GER
per_PIN
$_$
0.25_CD
Ordinary_NN
Share_NN
2003 2002 2001_CD
Net_JJ
profit_NN
for_PIN
the_DT
financial_JJ
year_NN
before_IN
exceptional_JJ
items_NN
$_$
m_CD [BEMA]
3,036_CD
3,186_CD
3,044_CD
Exceptional_JJ
items_NN
after_IN
tax_NN
$_$
m_CD
see_VPRT [PRIV]
Note_NN
3_CD
350_CD
138_CD
Net_JJ
profit_NN
for_PIN
the_DT
financial_JJ
year_NN
$_$
m_CD [BEMA]
3,036_CD
2,836_CD
2,906_CD
Earnings_GER
per_PIN
Ordinary_NN
Share_NN
before_IN
exceptional_JJ
items_NN
$_$
1.78_CD
$_$
1.84_CD
$_$
1.73_CD
Loss_NN
per_PIN
Ordinary_NN
Share_NN
on_PIN
exceptional_JJ
items_NN
$_$
0.20_CD
$_$
0.08_CD
Earnings_GER
per_PIN
Ordinary_NN
Share_NN
$_$
1.78_CD
$_$
1.64_CD
$_$
1.65_CD
Diluted_VBN
earnings_GER
per_PIN
Ordinary_NN
Share_NN
before_IN
exceptional_JJ
items_NN
$_$
1.78_CD
$_$
1.84_CD
$_$
1.73_CD
Diluted_VBN
loss_NN
per_PIN
Ordinary_NN
Share_NN
on_PIN
exceptional_JJ
items_NN
$_$
0.20_CD
$_$
0.08_CD
Diluted_VBN
earnings_GER
per_PIN
Ordinary_NN
Share_NN
$_$
1.78_CD
$_$
1.64_CD
$_$
1.65_CD
Weighted_VBN
average_JJ
number_NN
of_PIN
Ordinary_NN
Shares_NN
in_PIN
issue_NN
for_PIN
basic_JJ
earnings_GER
millions_NN
1,709_CD
1,733_CD
1,758_CD
Dilutive_JJ
impact_NN
of_PIN
share_NN
options_NOMZ
outstanding_JJ
millions_NN
3_CD
23_CD
Diluted_VBN
average_JJ
number_NN
of_PIN
Ordinary_NN
Shares_NN
in_PIN
issue_NN
millions_NN
1,712_CD
1,735_CD
1,761_CD
There_EX
are_VPRT
no_SYNE
options_NOMZ
,_,
warrants_NN
or_CC
rights_NN
outstanding_JJ
in_PIN
respect_NN
of_PIN
unissued_JJ
shares_NN
except_PIN
for_PIN
employee_NN
share_NN
option_NOMZ
schemes_NN
._.
The_DT
number_NN
of_PIN
options_NOMZ
outstanding_JJ
and_CC
the_DT
weighted_JJ
average_JJ
exercise_NN
price_NN
of_PIN
these_DEMO
options_NOMZ
is_VPRT [PASS]
shown_VBN [PRIV]
in_PIN
Note_NN
30_CD
._.
The_DT
earnings_GER
figures_NN
used_VBN [WZPAST]
in_PIN
the_DT
calculations_NOMZ
above_PLACE
are_VPRT [BEMA]
unchanged_PRED
for_PIN
diluted_JJ
earnings_GER
per_PIN
Ordinary_NN
Share_NN
._.
Earnings_GER
per_PIN
Ordinary_NN
Share_NN
before_IN
exceptional_JJ
items_NN
have_VPRT [PEAS]
been_VBN [PASS]
calculated_VBN [PRIV]
to_TO
eliminate_VB
the_DT
impact_NN
of_PIN
exceptional_JJ
items_NN
on_PIN
the_DT
results_NN
of_PIN
the_DT
business_NOMZ
._.
